Skip to content

A study to compare the benefits of using cord blood serum eye drop versus heparin eye drops versus applying amniotic membrane on acute Stevens Johnson Syndrome patients eyes to reduce inflammation and improve vision

Comparative Evaluation Of Umbilical Cord Blood Serum Versus Low Dose Heparin Drops Versus Amniotic Membrane Grafting For Ocular Manifestations In Acute Stevens-Johnson Syndrome - nil

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/071587
Enrollment
90
Registered
2024-07-30
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical Health Condition 2: L511- Stevens-Johnson syndrome

Interventions

Intervention1: 20% Umbilical cord blood serum eye drops (in saline): This will be given 4 times a day for three months Intervention2: Low Dose Heparin Eye drop (100ui/ml): this will be administered fo

Sponsors

Dr R.P.Centre for Ophthalmic Sciences, AIIMS
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a) Patients diagnosed with acute SJS with ocular involvement. b) Aged 18 years or older. c) Willing to provide informed consent

Exclusion criteria

Exclusion criteria: a) Patients with a history of pre-existing ocular conditions that could interfere with the study results. b) Patients with known allergies to any of the study components. c) Pregnant or lactating women

Design outcomes

Primary

MeasureTime frame
Improvement in best corrected visual acuity (BCVA)Timepoint: Day 0, Day 3, Day 7, Day 14, Day30, Day 60, Day 90, Day 120, Day 150, Day 180.

Secondary

MeasureTime frame
1. Ocular pain and discomfort (OSDI questionnaire) 2. Severity scoring of ocular manifestations (Gregory et al grading system)Timepoint: Day 0, Day 3, Day 7, Day 14, Day30, Day 60, Day 90, Day 120, Day 150, Day 180.

Countries

India

Contacts

Public ContactDr Namrata Sharma

AIIMS, New Delhi

namrata.sharma@gmail.com9868398412

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026